✦ LIBER ✦

Assessment of HER2 status in breast cancer: why, when and how?

✍ Scribed by M Dowsett; T Cooke; I Ellis; W.J Gullick; B Gusterson; E Mallon; R Walker

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tissue microarray technology in the rout

✍ Jane Cryan; Anthony O’Grady; David Allen; Elaine Kay 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB

Comparison of fluorescencein situhybridi

✍ Lin Wang; Xiaobei Wang; Xiu Nie; Ling Ma 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 Chinese ⚖ 428 KB

Impact of chromosome 17 centromere regio

✍ Kristof Egervari; Csaba Kosa; Zoltan Szollosi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 274 KB

Comparison between immunohistochemistry

✍ Nataša Todorović-Raković; Danica Jovanović; Zora Nešković-Konstantinović; Dragic 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB

Molecular diagnostics for determination

✍ J.M.S. Bartlett; E. Mallon; T. Cooke 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Concordant HER2 status between metastati

✍ In Hae Park; Youngmee Kwon; Jae Y. Ro; Keun Seok Lee; Jungsil Ro 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 207 KB